Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore

Experimental Cell Research

Volumn 249, Issue 2, 1999, Pages 413-421

  Larochette, Nathanael ^a   Decaudin, Didier ^a,b   Jacotot, Etienne ^a   Brenner, Catherine ^a,c   Marzo, Isabel ^a   Susin, Santos A ^a   Zamzami, Naoufal ^a   Xie, Zhihua ^d   Reed, John ^d   Kroemer, Guido ^a  

^a CNRS   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^d BURNHAM INSTITUTE   (United States)

Author keywords

Arsenic oxide; Mitochondrial megachannel; Phenylarsine oxide; Programmed cell death

Indexed keywords

ARSENIC TRIOXIDE; BENZODIAZEPINE RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; DRUG SCREENING; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033563729     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4519     Document Type: Article

References (56)

1. Aposhian H. V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:1997;397-419.
2. 3) in the treatment of acute promyelocytic leukemia: II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 89:1997;3354-3360.
3. Soignet S. L., Maslak P., Wang Z. G., Jhanwar S., Calleja E., Dardashti L. J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D. A., Pandolfi P. P., Warrell R. P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Engl. J. Med. 339:1998;1341-1348.
4. 3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood. 88:1996;1052-1061.
5. Konig A., Wrazel L., Warrell R. P., Rivi R., Pandolfi P. P., Jakubowski A., Gabrilove J. L. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood. 90:1997;562-570.
6. Gianni M., Koken M. H. M., Chelbi-Alix M. K., Benoit G., Lanotte M., Chen Z., de Thé H. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. Blood. 91:1998;4300-4310.
7. Zhang W., Ohnishi K., Shigeno K., Fujisawa S., Naito K., Nakamura S., Takeshita K., Takeshita A., Ohno R. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia. 12:1998;1383-1391.
8. Akao Y., Mizoguchi H., Kojima S., Naoe T., Ohishi N., Yagi K. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: Activation of caspases and down-regulation of Bcl-2 protein. Br. J. Haematol. 102:1998;1055-1060.
9. Wang Z. G., Rivi R., Delva L., Konig A., Scheinberg D. A., Gambacorti-Passerini C., Gabrilove J. L., Warrell R. P., Pandolfi P. P. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemic cell lines and function in a PML and PML-RAR alpha independent fashion. Blood. 92:1998;1497-1504.
10. Mirkes P. E., Little S. A. Teratogen-induced cell death in postimplantation mouse embryos: Differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ. 5:1998;592-600.
11. Chen Y. C., Lin Shiau S. Y., Lin J. K. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell. Physiol. 177:1998;324-333.
12. Doza Y. N., Hall-Jackson C. A., Cohen P. Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of GrB2-Sos. Oncogene. 17:1998;19-24.
13. Quignon F., DeBels F., Koken M., Feunteun J., Ameisen J. C., de Thé H. PML induces a novel caspase-independent death process. Nat. Gen. 20:1998;259-265.
14. Kroemer G., Petit P. X., Zamzami N., Vayssière J.-L., Mignotte B. The biochemistry of apoptosis. FASEB J. 9:1995;1277-1287.
15. Marzo I., Brenner C., Zamzami N., Susin S. A., Beutner G., Brdiczka D., Rémy R., Xie Z.-H., Reed J. C., Kroemer G. The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2 related proteins. J. Exp. Med. 187:1998;1261-1271.
16. Marzo I., Brenner C., Zamzami N., Jürgensmeier J., Susin S. A., Vieira H. L. A., Prévost M.-C., Xie Z., Mutsiyama S., Reed J. C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
17. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R. J., Matsuda H., Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95:1998;14681-14686.
18. Liu X. S., Kim C. N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
19. Zamzami N., Susin S. A., Marchetti P., Hirsch T., Gómez-Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1996;1533-1544.
20. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
21. Lenartowicz E., Bernardi P., Azzone G. F. Phenylarsine oxide induces the cyclosporine-A-sensitive membrane permeability transition in rat liver mitochondria. J. Bioenerg. Biomembr. 23:1991;679-688.
22. Bernardi P., Vassanelli S., Veronese P., Colonna R., Szabò I., Zoratti M. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267:1992;2934-2939.
23. Pastorino J. G., Snyder J. W., Serroni A., Hoek J. B., Farber J. L. Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J. Biol. Chem. 268:1993;13791-13798.
24. Connern C. P., Halestrap A. P. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302:1994;321-324.
25. Petronilli V., Costantini P., Scorrano L., Colonna R., Passamonti S., Bernardi P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269:1994;16638-16642.
26. Costantini P., Chernyak B. V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271:1996;6746-6751.
27. Haeffner A., Mollereau B., Deas O., Estaquier J., Mignon A., Haeffner-Cavaillon N., Charpentier B., Senik A., Hirsch F. Growth hormone prevents human monocytic cells from Fas-mediated apoptosis by up-regulation of Bcl-2 expression. Eur. J. Immunol. 29:1999;334-344.
28. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
29. Marchetti P., Castedo M., Susin S. A., Zamzami N., Hirsch T., Haeffner A., Hirsch F., Geuskens M., Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1996;1155-1160.
30. Kroemer G., Bosca L., Zamzami N., Hortelano S., Martinez-A. C. Detection of apoptosis and apoptosis associated alterations. Lefkovitz R. The Immunology Methods Manual. 1997;1111-1125 Academic Press, San Diego.
31. Leist M., Single B., Castoldi A. F., Kühnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486.
32. Green D. R., Mahboubi A., Nishioka W., Oja S., Echeverri F., Shi Y., Glynn J., Yang Y., Ashwell J., Bissonnette R. Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunol. Rev. 142:1994;321-342.
33. Susin S. A., Larochette N., Geuskens M., Kroemer G. Purification of mitochondria for apoptosis assays. Methods Enzymol. 1999.
34. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1342.
35. Wood E. R., Earnshaw W. C. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J. Cell Biol. 111:1990;2839-2850.
36. Susin S. A., Zamzami N., Larochette N., Dallaporta B., Marzo I., Brenner C., Hirsch T., Petit P. X., Geuskents M., Kroemer G. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system. Application to ceramide-induced apoptosis. Exp. Cell Res. 236:1997;397-403.
37. Susin S. A., Zamzami N., Castedo M., Daugas E., Wang H.-G., Geley S., Fassy F., Reed J., Kroemer G. The central executioner of apoptosis. Multiple links between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186:1997;25-37.
38. Brenner C., Marzo I., de Araujo Vieira H. L., Kroemer G. Purification and liposomal reconstitution of the permeability transition pore complex. Methods Enzymol. 1999.
39. Schendel S., Xie Z., Montal M. O., Matsuyama S., Montal M., Reed J. C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;5113-5118.
40. Zamzami N., Marzo I., Susin S. A., Brenner C., Larochette N., Marchetti P., Reed J., Kofler R., Kroemer G. The thiol-crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene. 16:1998;1055-1063.
41. Hirsch T., Decaudin D., Susin S. A., Marchetti P., Larochette N., Resche-Rigon M., Kroemer G. PK11195, a ligand of the mitochondrial benzodiazepin receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res. 241:1998;426-434.
42. Miccoli L., Poirson-Bichat F., Sureau F., Gonçalves R. B., Bourgeois Y., Dutrillaux B., Poupon M.-F., Oudard S. Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment. J. Natl. Cancer Inst. 1998;1400-1406.
43. McCarthy N. J., Whyte M. K. B., Gilbert C. S., Evan G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
44. Green D. R., Kroemer G. The central execution of apoptosis: Mitochondria or caspases. Trends Cell Biol. 8:1998;267-271.
45. Samejima K., Toné S., Kottke T. J., Enari M., Sakahira H., Cooke C. A., Durrieu F., Martins L. M., Nagata S., Kaufmann S. H., Earnshaw W. C. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J. Cell Biol. 143:1998;225-239.
46. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
47. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D. R., Aebersold R., Siderovski D. P., Penninger J. M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor (AIF). Nature. 397:1999;441-446.
48. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Larochette N., Alzari P. M., Kroemer G. Mitochondrial release of caspases-2 and -9 during the apoptotic process. J. Exp. Med. 189:1999;381-394.
49. Mancini M., Nicholson D. W., Roy S., Thornberry N. A., Peterson E. P., Casciola-Rosen L. A., Rosen A. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling. J. Cell Biol. 140:1998;1485-1495.
50. Deas O., Dumont C., MacFarlane M., Rouleau M., Hebib C., Harper F., Hirsch F., Charpentier B., Cohen G. M., Senik A. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161:1998;3375-3383.
51. Polyak K., Xia Y., Zweier J. L., Kinzler K. W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
52. DeMaria R., Lenti L., Malisan F., d'Agostino F., Tomassini B., Zeuner A., Rippo M. R., Testi R. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 277:1997;1652-1655.
53. Kolesnick R. M., Kronke M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60:1998;643-665.
54. Fulda S., Sieverts H., Friesen C., Herr I., Debatin K. M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57:1997;3823-3929.
55. Herr I., Wilhelm D., Bohler T., Angel P., Debatin K. M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16:1997;6200-6208.
56. Testi R. Sphingomyelin breakdown and cell fate. Trends Biochem. Sci. 21:1996;468-471.